|
GTPBP10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.182200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.133210E-01 |
| Normal-vs-Stage2 |
3.824200E-01 |
| Normal-vs-Stage3 |
4.720200E-01 |
| Normal-vs-Stage4 |
2.781400E-01 |
| Stage1-vs-Stage2 |
6.813400E-01 |
| Stage1-vs-Stage3 |
1.514610E-01 |
| Stage1-vs-Stage4 |
1.968170E-01 |
| Stage2-vs-Stage3 |
2.633600E-01 |
| Stage2-vs-Stage4 |
1.817180E-01 |
| Stage3-vs-Stage4 |
6.782000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.077170E-01 |
| Normal-vs-AfricanAmerican |
5.917800E-01 |
| Normal-vs-Asian |
5.103600E-01 |
| Caucasian-vs-AfricanAmerican |
6.466000E-01 |
| Caucasian-vs-Asian |
8.252600E-01 |
| AfricanAmerican-vs-Asian |
7.350000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.027600E-02 |
| Normal-vs-Female |
3.937000E-01 |
| Male-vs-Female |
8.402200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.210800E-01 |
| Normal-vs-Extreme_Weight |
3.870800E-01 |
| Normal-vs-Obese |
2.471000E-01 |
| Normal-vs-Extreme_Obese |
6.710200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.042800E-01 |
| Normal_Weight-vs-Obese |
2.114800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.739800E-01 |
| Extreme_Weight-vs-Obese |
6.782000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.742400E-01 |
| Obese-vs-Extreme_Obese |
9.560600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.986600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.149700E-02 |
| Normal-vs-Age(61-80Yrs) |
4.181400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.828200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.578000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.690400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.364400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.251800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.461200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.557800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.442400E-04 |
| Normal-VS-Type2 PRCC |
5.219600E-01 |
| Normal-VS-KIRP CIMP |
4.214400E-02 |
| Normal-VS-Unclassified PRCC |
9.885400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.235700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.338000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.406400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.825790E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.640600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.285560E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.955600E-01 |
| Normal-vs-N1 |
5.380800E-01 |
| Normal-vs-N2 |
1.297630E-01 |
| N0-vs-N1 |
9.236000E-01 |
| N0-vs-N2 |
1.600630E-01 |
| N1-vs-N2 |
9.776300E-02 |
|
|
